Tsaiyu Chiang
Affiliations: | 2013-2015 | Biomedical Engineering | National Tsing Hua University, Hsinchu City, Taiwan, ROC |
Google:
"Tsaiyu Chiang"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Huang SS, Lee KJ, Chen HC, et al. (2021) Immune cell shuttle for precise delivery of nanotherapeutics for heart disease and cancer. Science Advances. 7 |
Sung YC, Liu YC, Chao PH, et al. (2018) Combined delivery of sorafenib and a MEK inhibitor using CXCR4-targeted nanoparticles reduces hepatic fibrosis and prevents tumor development. Theranostics. 8: 894-905 |
Chih-Chun C, Yang Y, Gao DY, et al. (2017) Docetaxel-carboxymethylcellulose nanoparticles ameliorate CCl4-induced hepatic fibrosis in Mice. Journal of Drug Targeting. 1-27 |
Liu CH, Chan KM, Chiang T, et al. (2016) Dual-functional nanoparticles targeting CXCR4 and delivering anti-angiogenic siRNA ameliorate liver fibrosis. Molecular Pharmaceutics |
Lin TT, Gao DY, Liu YC, et al. (2015) Development and characterization of sorafenib-loaded PLGA nanoparticles for the systemic treatment of liver fibrosis. Journal of Controlled Release : Official Journal of the Controlled Release Society |
Liu JY, Chiang T, Liu CH, et al. (2015) Delivery of siRNA Using CXCR4-targeted Nanoparticles Modulates Tumor Microenvironment and Achieves a Potent Antitumor Response in Liver Cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy |